Internal Medicine, Endocrinology, Diabetes, & Metabolism · Chesapeake, VA
NPI
1659462398
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3205 Churchland Blvd
Chesapeake, VA, 23321
Phone (757) 484-7822
Groups this clinician bills Medicare through
Medicare paid, 2024
$252K
5,215 services
Medicare patients, 2024
895
Average age 73
Drug cost, 2024
$4.4M
8,009 prescriptions
Company payments, 2025
$1,757
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James C Larocque was code 99215 (office e&m - established), 1,288 times for 645 patients. In total James C Larocque billed 5,215 services in 26 codes, and Medicare paid $252K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-06-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 1,288 | 645 | $122.87 | $158K |
| 82962 Clinical Chemistry | Office | 999 | 443 | $3.20 | $3,198 |
| 83036 Blood Count | Office | 831 | 405 | $9.52 | $7,911 |
| 80061 Clinical Chemistry | Office | 733 | 383 | $13.12 | $9,617 |
| 95251 Test - Miscellaneous | Office | 386 | 175 | $25.19 | $9,723 |
| 99213 Office E&M - Established | Office | 216 | 183 | $56.96 | $12K |
| 99214 Office E&M - Established | Office | 129 | 99 | $85.08 | $11K |
| 76536 Ultrasound - Nonspecific | Office | 121 | 112 | $71.19 | $8,615 |
| 99205 Office E&M - New | Office | 81 | 81 | $146.23 | $12K |
| G0008 Administration of influenza virus vaccine | Office | 66 | 64 | $31.41 | $2,073 |
| 36415 Venipuncture Blood Collection | Office | 59 | 50 | $8.65 | $510 |
| 77080 Standard X-ray | Office | 58 | 58 | $37.84 | $2,195 |
| 99233 Hospital E&M - Subsequent | Facility | 49 | 20 | $91.13 | $4,465 |
| 90661 Vaccine Product | Office | 49 | 49 | $36.11 | $1,769 |
| 99223 Hospital E&M - Initial | Facility | 28 | 27 | $133.03 | $3,725 |
By year: 2022 $297K for 5,579 services; 2023 $268K for 5,382 services; 2024 $252K for 5,215 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 999 | 443 | $3.20 | $3,198 |
| 83036 Blood Count | 831 | 405 | $9.52 | $7,911 |
| 80061 Clinical Chemistry | 733 | 383 | $13.12 | $9,617 |
| 36415 Venipuncture Blood Collection | 59 | 50 | $8.65 | $510 |
Medicare prescription drug claims, 2024
In 2024, the drug James C Larocque prescribed most often to Medicare patients was Levothyroxine Sodium, with 855 prescriptions and refills. In total James C Larocque wrote 8,009 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 855 | 2,386 | 256 | $10K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 525 | 1,270 | 180 | $98K |
| Jardiance Empagliflozin | 366 | 761 | 97 | $442K |
| Metformin Hcl Generic | 360 | 1,033 | 123 | $2,325 |
| Ozempic Semaglutide | 293 | 592 | 80 | $573K |
| Trulicity Dulaglutide | 289 | 558 | 85 | $542K |
| Pioglitazone Hcl Generic | 274 | 788 | 91 | $3,437 |
| Liothyronine Sodium Generic | 236 | 637 | 79 | $9,587 |
| Synthroid Levothyroxine Sodium | 234 | 668 | 64 | $19K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 214 | 577 | 99 | $26K |
| Glimepiride Generic | 193 | 557 | 73 | $1,281 |
| Humalog Kwikpen U-100 Insulin Lispro | 178 | 440 | 75 | $87K |
| Farxiga Dapagliflozin Propanediol | 163 | 380 | 45 | $206K |
| Raloxifene Hcl Generic | 154 | 442 | 48 | $7,451 |
| Letrozole Generic | 150 | 440 | 46 | $1,216 |
Brand drugs: 3,808 claims; generic drugs: 3,551 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James C Larocque $1,757 ($1,757 in general payments such as food, travel and fees) from 22 companies. The largest payer was Corcept Therapeutics with $408.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.